Oral fludarabine and cyclophosphamide in previously untreated chronic lymphocytic leukemia (CLL): Preliminary data.

被引：0
|
作者：
Cazin, B
Binet, JL
Divine, M
Lepretre, S
Lederlin, P
Travade, P
Lemaire, G
Guibon, O
机构：
[1] CHU Lille, F-59037 Lille, France
[2] CHU, Paris, France
[3] CHU, Creteil, France
[4] CHU, Rouen, France
[5] CHU, Nancy, France
[6] CHU, Clermont Ferrand, France
[7] Schering SA, Dardilly, France
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2218
引用
收藏
页码：515A / 515A
页数：1
相关论文
共 50 条
  • [41] 2-CHLORODEOXYADENOSINE (CDA) FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    DELANNOY, A
    MARTIAT, P
    BOSLY, A
    FERRANT, A
    DENEYS, V
    MICHAUX, JL
    BLOOD, 1994, 84 (10) : A461 - A461
  • [42] Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia
    Shustik, C.
    Turner, A. R.
    Desjardins, P.
    Fernandez, L.
    Rubin, S.
    Larratt, L.
    Duncan, A. M. V.
    Rizi, D.
    Sadura, A.
    Shepherd, L.
    Li, D.
    Rassenti, L.
    Kipps, T.
    LEUKEMIA, 2010, 24 (01) : 237 - 239
  • [43] Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia
    C Shustik
    A R Turner
    P Desjardins
    L Fernandez
    S Rubin
    L Larratt
    A M V Duncan
    D Rizi
    A Sadura
    L Shepherd
    D Li
    L Rassenti
    T Kipps
    Leukemia, 2010, 24 : 237 - 239
  • [44] A phase II study of lenalidomide in previously untreated, symptomatic chronic lymphocytic leukemia (CLL)
    Chen, Christine I.
    Paul, Harminder
    Mariela, Pantoja
    Brandwein, Joseph
    Kukreti, Vishal
    Trudel, Suzanne
    Wei, Ellen
    Tong, Jieffei
    Moran, Mike
    BLOOD, 2007, 110 (11) : 608A - 608A
  • [45] A Phase II Stud of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
    Chen, Christine
    Paul, Harminder
    Xu, Wei
    Kukreti, Vishal
    Trudel, Suzanne
    Wei, Ellen
    Li, Zhi Hua
    Brandwein, Joseph
    Pantoja, Mariela
    Leung-Hagensteijn, Chungyee
    BLOOD, 2008, 112 (11) : 23 - 23
  • [46] LOW DOSE ORAL FLUDARABINE PLUS CYCLOPHOSPHAMIDE IN ELDERLY PATIENTS WITH UNTREATED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (RETROSPECTIVE STUDY)
    Ionita, H.
    Ionita, I.
    Nicola, D. E.
    Pacurar, R.
    Ionita, C. O.
    Cheveresan, M.
    Borzak, G.
    Ionita, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 523 - 524
  • [47] FLUDARABINE THERAPY IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    KEATING, MJ
    KANTARJIAN, H
    TALPAZ, M
    REDMAN, J
    MCCREDIE, KB
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1988, 30 (5-6): : 461 - 466
  • [48] Low doses of oral fludarabine in previously untreated elderly patients affected by chronic lymphocytic leukemia: Experience of a single unit
    Quirino, A. A.
    Villa, M. R.
    Improta, S.
    Lucania, A.
    Sagristani, M.
    Correale, F.
    Mastrullo, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 116 - 116
  • [49] Oral fludarabine and cyclophosphamide plus rituximab in the treatment of the chronic lymphocytic leukemia.
    Casula, P
    Sorano, G
    Pulixi, D
    Culurgioni, F
    Angelucci, E
    BLOOD, 2005, 106 (11) : 341B - 342B
  • [50] Combined chemotherapy with fludarabine, cyclophosphamide and rituximab (FCR) for relapsed or untreated progressive chronic lymphocytic leukemia (CLL). A single center experience.
    Pavlovsky, S
    Pavlovsky, C
    Pardo, L
    Sapia, S
    Fernandez, II
    Juni, M
    BLOOD, 2005, 106 (11) : 340B - 340B
12345